The human oligodendrocyte proteome

Proteomics

Volumn 13, Issue 23-24, 2013, Pages 3548-3553

  Iwata, Keiko ^a,b,c   Café Mendes, Cecilia C ^d,e   Schmitt, Andrea ^a,e   Steiner, Johann ^f   Manabe, Takayuki ^g   Matsuzaki, Hideo ^b,c   Falkai, Peter ^a   Turck, Christoph W ^d   Martins de Souza, Daniel ^a,d,e  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF FUKUI   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f OTTO VON GUERICKE UNIVERSITY   (Germany)

^g FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Biomedicine; Brain; MO3.13; Multiple sclerosis; Oligodendrocytes; Schizophrenia

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; GALACTOSYLCERAMIDE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NERVE PROTEIN; PROTEOME; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHROMOSOME; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SCHIZOPHRENIA; TROPICAL SPASTIC PARAPARESIS;

BIOMEDICINE; BRAIN; MO3.13; MULTIPLE SCLEROSIS; OLIGODENDROCYTES; SCHIZOPHRENIA;

CELL LINE; DATABASES, PROTEIN; HUMANS; MYELIN BASIC PROTEIN; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PROTEIN ISOFORMS; PROTEIN SUBUNITS; PROTEOME;

EID: 84890266362     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300201     Document Type: Article

References (48)

1. Polak, M., Haymaker, W., Johnson, J. E., D'Amelio, F., Neuroglia and their reactions, in: Haymaker, W., Adams, R. D. (Eds.), Histology and Histopathology of the Nervous System, Charles C. Thomas Springfield, IL 1982, pp. 363-480.
2. Du, Y., Dreyfus, C. F., Oligodendrocytes as providers of growth factors. J. Neurosci. Res. 2002, 68, 647-654.
3. Compston, A., Coles, A., Multiple sclerosis. Lancet 2002, 359, 1221-1231.
4. Martins-de-Souza, D., Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. J. Psychiatr. Res. 2010, 44, 149-156.
5. Segal, D., Koschnick, J. R., Slegers, L. H., Hof, P. R., Oligodendrocyte pathophysiology: a new view of schizophrenia. Int. J. Neuropsychopharmacol. 2007, 10, 503-511.
6. Post, G. R., Dawson, G., Characterization of a cell line derived from a human oligodendroglioma. Mol. Chem. Neuropathol. 1992, 16, 303-317.
7. McLaurin, J., Trudel, G. C., Shaw, I. T., Antel, J. P., Cashman, N. R., A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J. Neurobiol. 1995, 26, 283-293.
8. Craighead, M. W., Tiwari, P., Keynes, R. G., Waters, C. M., Human oligodendroglial cell line, MO3.13, can be protected from apoptosis using the general caspase inhibitor zVAD-FMK. J. Neurosci. Res. 1999, 57, 236-243.
9. Numata, Y., Morimura, T., Nakamura, S., Hirano, E. et al., Depletion of molecular chaperones from the endoplasmic reticulum and fragmentation of the Golgi apparatus associated with pathogenesis in Pelizaeus-Merzbacher disease. J. Biol. Chem. 2013, 288, 7451-7466.
10. Yao, S. Y., Natarajan, C., Sriram, S., nNOS mediated mitochondrial injury in LPS stimulated oligodendrocytes. Mitochondrion 2012, 12, 336-344.
11. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins silver-stained polyacryl-amide gels. Anal. Chem. 1996, 68, 850-858.
12. Maccarrone, G., Rewerts, C., Lebar, M., Turck, C. W., Martins-de-Souza, D., Proteome profiling of peripheral mononuclear cells from human blood. Proteomics 2013, 13, 893-897.
13. Vaudel, M., Barsnes, H., Berven, F. S., Sickmann, A., Martens, L., SearchGUI: an open-source graphical user interface for simultaneous OMSSA and X!Tandem searches. Proteomics 2011, 11, 996-999.
14. Barsnes, H., Vaudel, M., Colaert, N., Helsens, K. et al., Compomics-utilities: an open-source Java library for computational proteomics. BMC Bioinform. 2011, 12, 70.
15. Vizcaino, J. A., Cote, R. G., Csordas, A., Dianes, J. A. et al., The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 2013, 41, D1063-D1069.
16. Mathivanan, S., Ahmed, M., Ahn, N. G., Alexandre, H. et al., Human Proteinpedia enables sharing of human protein data. Nat. Biotechnol. 2008, 26, 164-167.
17. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C. et al., Proteome analysis of human dorsolateral prefrontal cortex using shotgun mass spectrometry. J. Sep. Sci. 2008, 31, 3122-3126.
18. Martins-de-Souza, D., Guest, P. C., Steeb, H., Pietsch, S. et al., Characterizing the proteome of the human dorsolateral prefrontal cortex by shotgun mass spectrometry. Proteomics 2011, 11, 2347-2353.
19. Woo, A. J., Dods, J. S., Susanto, E., Ulgiati, D., Abraham, L. J., A proteomics approach for the identification of DNA binding activities observed in the electrophoretic mobility shift assay. Mol. Cell. Proteomics 2002, 1, 472-478.
20. Paik, Y. K., Omenn, G. S., Uhlen, M., Hanash, S. et al., Standard guidelines for the chromosome-centric human proteome project. J. Proteome Res. 2012, 11, 2005-2013.
21. Dreyfuss, G., Kim, V. N., Kataoka, N., Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell. Biol. 2002, 3, 195-205.
22. Dreyfuss, G., Matunis, M. J., Pinol-Roma, S., Burd, C. G., hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem. 1993, 62, 289-321.
23. Krecic, A. M., Swanson, M. S., hnRNP complexes: composition, structure, and function. Curr. Opin. Cell. Biol. 1999, 11, 363-371.
24. Zhao, L. X., Mandler, M. D., Yi, H., Feng, Y., Quaking I controls a unique cytoplasmic pathway that regulates alternative splicing of myelin-associated glycoprotein. P. Natl. Acad. Sci. USA 2010, 107, 19061-19066.
25. Zearfoss, N. R., Clingman, C. C., Farley, B. M., McCoig, L. M., Ryder, S. P., Quaking regulates Hnrnpa1 expression through Its 3' UTR in oligodendrocyte precursor cells. PLoS Genet. 2011, 7, e1001269.
26. Carson, J. H., Gao, Y., Tatavarty, V., Levin, M. K. et al., Multiplexed RNA trafficking in oligodendrocytes and neurons. Biochim. Biophys. Acta 2008, 1779, 453-458.
27. Iwata, K., Matsuzaki, H., Manabe, T., Mori, N., Altering the expression balance of hnRNP C1 and C2 changes the expression of myelination-related genes. Psychiatry Res. 2011, 190, 364-366.
28. Wang, E. M., Dimova, N., Cambi, F., PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes. Nucleic Acids Res. 2007, 35, 4164-4178.
29. Wang, E. M., Cambi, F., Heterogeneous nuclear ribonucleoproteins H and F regulate the proteolipid protein/DM20 ratio by recruiting U1 small nuclear ribonucleoprotein through a complex array of G runs. J. Biol. Chem. 2009, 284, 11194-11204.
30. Laursen, L. S., Chan, C. W., Ffrench-Constant, C., Translation of myelin basic protein mRNA in oligodendrocytes is regulated by integrin activation and hnRNP-K. J. Cell Biol. 2011, 192, 797-811.
31. Bekenstein, U., Soreq, H., Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles. Mol. Cell. Neurosci. 2013, 56, 436-446.
32. Yukitake, M., Sueoka, E., Sueoka-Aragane, N., Sato, A. et al., Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J. Neurovirol. 2008, 14, 130-135.
33. Sueoka, E., Yukitake, M., Iwanaga, K., Sueoka, N. et al., Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients. Ann. Neurol. 2004, 56, 778-786.
34. Martins-De-Souza, D., Gattaz, W. F., Schmitt, A., Novello, J. C. et al., Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry 2009, 9, 17.
35. Fulton, D., Paez, P. M., Campagnoni, A. T., The multiple roles of myelin protein genes during the development of the oligodendrocyte. ASN Neuro. 2010, 2, e00027.
36. Harauz, G., Boggs, J. M., Myelin management by the 18.5-kDa and 21.5-kDa classic myelin basic protein isoforms. J. Neurochem. 2013, 125, 334-361.
37. Lee, J., Gravel, M., Zhang, R., Thibault, P., Braun, P. E., Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J. Cell. Biol. 2005, 170, 661-673.
38. Fujii, T., Iwane, A. H., Yanagida, T., Namba, K., Direct visualization of secondary structures of F-actin by electron cryomicroscopy. Nature 2010, 467, 724-728.
39. Mullins, R. D., Hansen, S. D., In vitro studies of actin filament and network dynamics. Curr. Opin. Cell. Biol. 2013, 25, 6-13.
40. Edgar, N. M., Touma, C., Palme, R., Sibille, E., Resilient emotionality and molecular compensation in mice lacking the oligodendrocyte-specific gene Cnp1. Transl. Psychiatry 2011, 1, e42.
41. Peirce, T. R., Bray, N. J., Williams, N. M., Norton, N. et al., Convergent evidence for 2', 3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch. Gen. Psychiatry 2006, 63, 18-24.
42. Zehner, Z. E., Regulation of intermediate filament gene expression. Curr. Opin. Cell. Biol. 1991, 3, 67-74.
43. Ebrahimi-Barough, S., Kouchesfehani, H. M., Ai, J., Mahmoodinia, M. et al., Programming of human endometrial-derived stromal cells (EnSCs) into pre-oligodendrocyte cells by overexpression of miR-219. Neurosci. Lett. 2013, 537, 65-70.
44. Osman, C., Merkwirth, C., Langer, T., Prohibitins and the functional compartmentalization of mitochondrial membranes. J. Cell Sci. 2009, 122, 3823-3830.
45. Theiss, A. L., Sitaraman, S. V., The role and therapeutic potential of prohibitin in disease. Biochim. Biophys. Acta 2011, 1813, 1137-1143.
46. Bernstein, H. G., Smalla, K. H., Durrschmidt, D., Keilhoff, G. et al., Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease. Neuromol. Med. 2012, 14, 270-280.
47. Varadarajulu, J., Schmitt, A., Falkai, P., Alsaif, M. et al., Differential expression of HINT1 in schizophrenia brain tissue. Eur. Arch. Psychiatry Clin. Neurosci. 2012, 262, 167-172.
48. Barbier, E., Wang, J. B., Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level. BMC Neurosci. 2009, 10, 132.